UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
PSYCHEMEDICS CORPORATION
(Name of Issuer)
Common Stock
Title of Class of Securities
744375205
(CUSIP Number)
APRIL 22, 2004
Date of Event which requires filing of this statement
Check the appropriate box to designate the rule pursuant to which this schedule
is filed:
[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5 Pages
CUSIP No. 744375205 Page 2 of 5 pages
SCHEDULE 13G
1) Names of Reporting Persons; S.S. or I.R.S. Identification Nos. of Above
Persons
Donald F. Flynn
--------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
-----------------------------------------------------------------------
(b)
-----------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------
4) Citizenship or Place of Organization U.S. Citizen
--------------------------------------
Number of Shares 5) Sole Voting Power 334,393
Beneficially Owned ---------------------------------
By Each Reporting 6) Shared Voting Power 0
Person With -------------------------------
7) Sole Dispositive Power 334,393
----------------------------
8) Shared Dispositive Power 0
--------------------------
9) Aggregate Amount Beneficially Owned by Each Reporting Person
334,393
--------------------------------------------------------------------------
10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
--------------------------------------------------------------------------
11) Percent of Class Represented by Amount in Row (9) 6.4%
-------------------------
12) Type of Reporting Person (See Instructions) IN
-------------------------------
CUSIP No. 744375205 Page 3 of 5 pages
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Item 1 (a) Name of Issuer: Psychemedics Corporation
(b) Address of Issuer's Principal Executive Offices:
1280 Massachusetts Ave., Suite 200
Cambridge, MA 02138
Item 2 (a) Name of Person Filing:
Donald F. Flynn
(b) Address of Principal Business Office or, if none, Residence:
676 North Michigan Avenue, Suite 4000,
Chicago, Illinois 60611
(c) Citizenship: U.S.
(d) Title of Class of Securities: Common Stock, $.005 par value
(e) CUSIP NUMBER: 744375205
Item 3 If this statement is filed pursuant to Sections 240.13d-1(b), or
240.13d-2(b) or (c), check whether the person filing is a:
Not Applicable
CUSIP No. 744375205 Page 4 of 5 pages
Item 4 (a) Amount Beneficially Owned: 334,393
(b) Percent of Class: 6.4%
(c) Number of Shares as to which such person has:
(i) sole power to direct the vote 334,393
(ii) shared power to vote or to direct the vote 0
(iii) sole power to dispose or to direct the disposition of
334,393
(iv) shared power to dispose or to direct the disposition of
0
Item 5 Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company:
Not Applicable
Item 8 Identification and Classification of Members of the Group:
Not Applicable
Item 9 Notice of Dissolution of Group:
Not Applicable
CUSIP No. 744375205 Page 4 of 5 pages
Item 10 Certification
(a) Not Applicable
(b) By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as participant in any transaction having
that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I
hereby certify that the information set forth in this statement is true,
complete and correct.
May 5, 2004
----------------------------------------
Date
/s/ Donald F. Flynn
----------------------------------------
Donald F. Flynn